Princeton Global Asset Management LLC
Position in GILD — Gilead Sciences, Inc.
CIK 1767349
PRINCETON, NJ
Position in GILD
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$201,385
-$23,418 QoQ
Shares Held
1,594
-1.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,914
of 2,266 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Princeton Global Asset Management LLC holds $25,670,962 across 14 Drug Manufacturers - General names. GILD ranks #5 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
41,882 | $10,636,771 | |
| 2 | LLY |
ELI LILLY & Co
|
5,815 | $6,974,686 | |
| 3 | ABBV |
AbbVie Inc.
|
26,493 | $6,666,698 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,825 | $491,512 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
1,594 | $201,385 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
3,450 | $198,789 | |
| 7 | AMGN |
Amgen Inc
|
499 | $180,697 | |
| 8 | AZN |
Astrazeneca PLC
|
828 | $157,005 |
All Filings in GILD
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $201,385 | 1,594 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $224,803 | 1,613 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $196,752 | 1,603 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $143,301 | 1,291 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $87,698 | 791 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $56,025 | 500 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $46,185 | 500 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $8,384 | 100 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $10,497 | 153 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $7,325 | 100 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $8,101 | 100 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $7,494 | 100 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $7,707 | 100 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $8,297 | 100 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $8,585 | 100 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $6,169 | 100 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,181 | 100 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $5,945 | 100 | Shares | Sole | 2022-05-06 | |
| 2020-12-31 | $3,495 | 60 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $3,791 | 60 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $4,616 | 60 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $4,485 | 60 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||